Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regadenoson and Optison for CAD Detection
NCT01489176Phase 3Completed
- Sponsor
- University of Nebraska
- Start
- Jul 2012
- Primary completion
- Apr 2014
- Countries
- 1
01
Overview
A Phase 3 trial of regadenoson in coronary artery disease (CAD), sponsored by University of Nebraska. Started Jul 2012; status: completed.
02
Drugs
regadenoson
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01489176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01489176.